Found 18 matching trials
A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema N/A This study is a survey in Japan of Icatibant subcutaneous injection 30 mg s...
Show More Location
Takeda selected site
Learn More & Join Trial
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema PHASE3 The purpose of this study is to assess the efficacy and safety of Icatibant...
Show More Location
Georgetown University Hospital, Lombardi Cancer Center
Learn More & Join Trial
A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema PHASE3 The main aim of the study is to check for side effects from icatibant in ch...
Show More Location
Aich Medical University Hospital
Learn More & Join Trial
Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers PHASE1 This is a single-dose study to evaluate the pharmacokinetics, safety, and t...
Show More Learn More & Join Trial
A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants PHASE3 The objective of this study is to evaluate the efficacy, pharmacokinetics (...
Show More Location
Fukushima Medical University Hospital
Learn More & Join Trial
Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema PHASE3 This study is being conducted to compare the safety and efficacy of icatiba...
Show More Location
University of California San Diego Medical Center
Learn More & Join Trial
Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema PHASE1 Individuals with heart disease or high blood pressure are often prescribed ...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema PHASE3 HGT-FIR-086 is a multicenter, open-label, non-randomized, single-arm study ...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3) PHASE3 This study is being conducted to evaluate the efficacy and safety of icatib...
Show More Location
Primary Care Associates of Alabaster
Learn More & Join Trial
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients PHASE2 The goal of this project is to rapidly screen promising agents, in the sett...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial